Cavadis is a Dutch biomedical company active in the field of cardiovascular risk assessment. We develop prognostic tests to identify patients at risk of cardiovascular disease. The company identified several novel biomarkers predictive for cardiovascular events. It is our goal is to develop clinically meaningful risk stratification tools that will help personalize treatment and achieve better patient outcomes.
Specialties
cardiovascular disease, biomarker, biomarker discovery, biomarker development, diagnostics, diagnostic tests, surrogate marker, clinical marker, proteomics, genomics, lipidomics, transcriptomics, prognostics, prognostic tests, exosomes, blood-based diagnostics
